FCF co-organized, along with its accomplice YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which was held on-line on June 21st & 24th, 2022.
ACCESS CHINA Biotech Discussion board is a quarterly company entry occasion collection between China and western biopharma. It’s the best deal-making platform for western pharma and biotech leaders trying to enter or increase within the Chinese language market. The occasion helps western biopharma corporations to effectively current their belongings on-line in entrance of 500+ biopharma corporations / 2000+ BD administrators and healthcare VCs in China. It creates invaluable BD alternatives by immediately connecting and assembly with the appropriate companions for growth, licensing or business collaborations. We hosted 100 firm displays, 10 keynote speeches, 1000+ contributors, and 250+ 1×1 conferences. Licensing exercise in China has been steadily growing over time.